Research ArticleEndocrine and Diabetes
The Dual Amylin- and Calcitonin-Receptor Agonist KBP-042 Works as Adjunct to Metformin on Fasting Hyperglycemia and HbA1c in a Rat Model of Type 2 Diabetes
Sara T. Hjuler, Sofie Gydesen, Kim V. Andreassen, Morten A. Karsdal and Kim Henriksen
Journal of Pharmacology and Experimental Therapeutics July 2017, 362 (1) 24-30; DOI: https://doi.org/10.1124/jpet.117.241281
Sara T. Hjuler
Department of Musculoskeletal Diseases, Nordic Bioscience Biomarkers and Research, Herlev, Denmark
Sofie Gydesen
Department of Musculoskeletal Diseases, Nordic Bioscience Biomarkers and Research, Herlev, Denmark
Kim V. Andreassen
Department of Musculoskeletal Diseases, Nordic Bioscience Biomarkers and Research, Herlev, Denmark
Morten A. Karsdal
Department of Musculoskeletal Diseases, Nordic Bioscience Biomarkers and Research, Herlev, Denmark
Kim Henriksen
Department of Musculoskeletal Diseases, Nordic Bioscience Biomarkers and Research, Herlev, Denmark

Submit a Response to This Article
Jump to comment:
No eLetters have been published for this article.
In this issue
Research ArticleEndocrine and Diabetes
KBP-042 as Adjunct Therapy to Metformin
Sara T. Hjuler, Sofie Gydesen, Kim V. Andreassen, Morten A. Karsdal and Kim Henriksen
Journal of Pharmacology and Experimental Therapeutics July 1, 2017, 362 (1) 24-30; DOI: https://doi.org/10.1124/jpet.117.241281